Introduction
Yesterday, we considered trial design conditions to establish one antibiotic for all.
Today, I wish to discuss the trial design issues if our goal becomes one antibiotic for each.
I will then show that the two approaches work well together to answer the questions of antibiotic efficacy for resistant microbes.